Laurus Labs Gets Board Nod to Invest INR833 Million in Joint Venture Company KRKA Pharma

MT Newswires Live

Mar 07, 2025

Laurus Labs (NSE:LAURUSLABS, BOM:540222) has received board approval to invest 833 million Indian rupees in the company's joint venture company KRKA Pharma, according to a Thursday filing to the Indian stock exchanges.

The company's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.

Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs.

The investment is expected to be completed by March 31.

The additional investment will be used by KRKA Pharma to acquire land and to meet the initial cost of setting up of a manufacturing facility for production of finished products for the new markets, including the Indian market.

Shares of the company were up over 1% in recent trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2517212145"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2517212145\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2517212145?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-07 13:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2517212145","market":"hk","top_or_hot":-1,"title":"Laurus Labs Gets Board Nod to Invest INR833 Million in Joint Venture Company KRKA Pharma","media":"MT Newswires Live","content":"<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has received board approval to invest 833 million Indian rupees in the company's joint venture company KRKA Pharma, according to a Thursday filing to the Indian stock exchanges.</p><p>The company's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs.</p><p>The investment is expected to be completed by March 31.</p><p>The additional investment will be used by KRKA Pharma to acquire land and to meet the initial cost of setting up of a manufacturing facility for production of finished products for the new markets, including the Indian market.</p><p>Shares of the company were up over 1% in recent trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laurus Labs Gets Board Nod to Invest INR833 Million in Joint Venture Company KRKA Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaurus Labs Gets Board Nod to Invest INR833 Million in Joint Venture Company KRKA Pharma\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-07 13:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has received board approval to invest 833 million Indian rupees in the company's joint venture company KRKA Pharma, according to a Thursday filing to the Indian stock exchanges.</p><p>The company's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs.</p><p>The investment is expected to be completed by March 31.</p><p>The additional investment will be used by KRKA Pharma to acquire land and to meet the initial cost of setting up of a manufacturing facility for production of finished products for the new markets, including the Indian market.</p><p>Shares of the company were up over 1% in recent trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JYNT","symbol_name":"The Joint Corp.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2517212145","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2517212145","pubTimestamp":1741325362,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Laurus Labs  has received board approval to invest 833 million Indian rupees in the company's joint venture company KRKA Pharma, according to a Thursday filing to the Indian stock exchanges.The company's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs.The investment is expected to be completed by March 31.The additional investment will be used by KRKA Pharma to acquire land and to meet the initial cost of setting up of a manufacturing facility for production of finished products for the new markets, including the Indian market.Shares of the company were up over 1% in recent trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"JYNT":"The Joint Corp.","BK4185":"保健护理机构"},"translate_title":"Laurus Labs获得董事会批准向合资公司KRKA Pharma投资8.33亿印度卢比","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JYNT":1},"content_text":"Laurus Labs (NSE:LAURUSLABS, BOM:540222) has received board approval to invest 833 million Indian rupees in the company's joint venture company KRKA Pharma, according to a Thursday filing to the Indian stock exchanges.The company's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto and Laurus Labs.The investment is expected to be completed by March 31.The additional investment will be used by KRKA Pharma to acquire land and to meet the initial cost of setting up of a manufacturing facility for production of finished products for the new markets, including the Indian market.Shares of the company were up over 1% in recent trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}